<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>iPump, Inc. &#187; fad advisory</title>
	<atom:link href="http://www.ipump.org/blog/tag/fad-advisory/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.ipump.org/blog</link>
	<description>a (501(c)(3) charity with a heart</description>
	<lastBuildDate>Wed, 13 Jan 2010 00:39:45 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA Early Communication About the Safety of Lantus (Insulin Glargine)</title>
		<link>http://www.ipump.org/blog/2009/07/08/fda-early-communication-about-the-safety-of-lantus-insulin-glargine/</link>
		<comments>http://www.ipump.org/blog/2009/07/08/fda-early-communication-about-the-safety-of-lantus-insulin-glargine/#comments</comments>
		<pubDate>Thu, 09 Jul 2009 02:09:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA Alerts, Recalls, Product Safety]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[fad advisory]]></category>
		<category><![CDATA[fda alerts]]></category>
		<category><![CDATA[insulin glargine]]></category>
		<category><![CDATA[lantus]]></category>

		<guid isPermaLink="false">http://www.ipump.org/blog/?p=43</guid>
		<description><![CDATA[FDA is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible risk for cancer in patients with diabetes. Three of the four studies suggest an increased risk for cancer associated with use of Lantus.]]></description>
		<wfw:commentRss>http://www.ipump.org/blog/2009/07/08/fda-early-communication-about-the-safety-of-lantus-insulin-glargine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
